Prognostic role of neutrophil lymphocyte ratio in patients with glioma

Jing Zhang; Sunfu Zhang; Yanlin Song; Min He; Qingqing Ren; Chaoyue Chen; Zhiyong Liu; Yunhui Zeng; Jianguo Xu

doi:10.18632/oncotarget.19484

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Prognostic role of neutrophil lymphocyte ratio in patients with glioma

Jing Zhang, Sunfu Zhang, Yanlin Song, Min He, Qingqing Ren, Chaoyue Chen, Zhiyong Liu, Yunhui Zeng and Jianguo Xu _

PDF | HTML | How to cite

Oncotarget. 2017; 8:59217-59224. https://doi.org/10.18632/oncotarget.19484

Metrics: PDF 3919 views | HTML 2487 views | ?

Abstract

Jing Zhang1,*, Sunfu Zhang1,*, Yanlin Song2,*, Min He1, Qingqing Ren1, Chaoyue Chen1, Zhiyong Liu1, Yunhui Zeng1 and Jianguo Xu1

1Department of Neurosurgery, West China Hospital of Sichuan University, The First People’s Hospital of Yibin, Sichuan, PR China

2West China School of Medicine, West China Hospital of Sichuan University, Sichuan, PR China

*These authors have contributed equally to this work

Correspondence to:

Jianguo Xu, email: [email protected]

Keywords: neutrophil lymphocyte ratio, glioma, survival, prognosis

Received: April 27, 2017 Accepted: June 20, 2017 Published: July 22, 2017

ABSTRACT

The purpose of this study was to evaluate the prognostic role of neutrophil lymphocyte ratio (NLR) in patients with glioma. PubMed, EMBASE, Cochrane Library and China National Knowledge Infrastructure were searched for relevant literature. The study and patient characteristics were extracted. Hazard ratios (HRs) with 95% confidence intervals (CIs) were pooled to estimate the prognostic role of NLR in patients with glioma. Subgroup analysis and sensitivity analysis were also performed. Six studies with 1,021 patients were included. The pooled HR of elevated NLR for OS in patients with glioma was 1.48 (95% CI, 1.25-1.76). Among the included studies, five studies used 4 as the cut-off value of NLR. The pooled HR for OS of the five studies was 1.67 (95% CI, 1.37-2.03). No significant heterogeneity was observed (I² = 42.4%, P=0. 122). Publication bias was not present. Elevated NLR was associated with poorer overall survival in patients with glioma.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 19484

Publication Alerts

Research Papers:

Prognostic role of neutrophil lymphocyte ratio in patients with glioma

Abstract